0001140361-16-059857.txt : 20160401 0001140361-16-059857.hdr.sgml : 20160401 20160401171513 ACCESSION NUMBER: 0001140361-16-059857 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160401 DATE AS OF CHANGE: 20160401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AFFYMETRIX INC CENTRAL INDEX KEY: 0000913077 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770319159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3420 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 4087315000 MAIL ADDRESS: STREET 1: 3420 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NACHTSHEIM JAMI K CENTRAL INDEX KEY: 0001223017 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28218 FILM NUMBER: 161548129 4 1 doc1.xml FORM 4 X0306 4 2016-03-31 0 0000913077 AFFYMETRIX INC AFFX 0001223017 NACHTSHEIM JAMI K C/O AFFYMETRIX, INC. 3420 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 1 0 0 0 Common Stock 2016-03-31 4 D 0 35662 D 0 D Stock Option (right to buy) 7.85 2016-03-31 4 D 0 20000 D Common Stock 20000 0 D Stock Option (right to buy) 5.88 2016-03-31 4 D 0 10000 D Common Stock 10000 0 D Stock Option (right to buy) 5.07 2016-03-31 4 D 0 10000 D Common Stock 10000 0 D Stock Option (right to buy) 3.68 2016-03-31 4 D 0 10000 D Common Stock 10000 0 D Stock Option (right to buy) 8.23 2016-03-31 4 D 0 20000 D Common Stock 20000 0 D Stock Option (right to buy) 12.37 2016-03-31 4 D 0 5053 D Common Stock 5053 0 D Pursuant to the Agreement and Plan of Merger dated as of January 8, 2016 by and among Affymetrix, Inc. ("Affymetrix"), Thermo Fisher Scientific Inc. ("Thermo Fisher") and White Birch Merger Co. (the "Merger Agreement"), (x) each outstanding share of common stock of Affymetrix was cancelled and converted into the right to receive $14.00 in cash; (y) each vested stock option was cancelled and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price; and (z) each unvested stock option and RSU, whether vested or unvested, was assumed by Thermo Fisher and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price, as applicable. /s/ Siang H. Chin, Attorney-in-Fact for Jami Nachtsheim 2016-04-01